FOLH1 and hepatocellular carcinoma: Overall, PSMA-targeting PET/CT or PET/MRI showed excellent diagnostic performance in detecting HCC lesions in all the studies included in the systematic review, both on a per-patient- and per-lesion-based analyses and in different clinical settings.